Human astrovirus coat protein: a novel C1 inhibitor

Neel K Krishna1, Kenji M Cunnion

  • 1Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA 23507, USA. krishnnk@evms.edu

Insights

Researchers discovered a novel inhibitor of C1, the astrovirus coat protein. This protein blocks complement activation, offering potential therapeutic benefits for inflammatory diseases.

Area of Science:

  • Immunology
  • Virology
  • Biochemistry

Background:

  • The complement system's classical pathway, initiated by the C1 complex (C1q, C1r, C1s), plays a crucial role in pathogen defense and immune regulation.
  • Dysregulated complement activation is implicated in various autoimmune and inflammatory conditions, necessitating effective control mechanisms.
  • Existing inhibitors of C1 are limited, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

  • To identify and characterize novel inhibitors of the C1 complex.
  • To investigate the potential of viral proteins as modulators of complement activation.
  • To explore the therapeutic implications of inhibiting the classical complement pathway.

Main Methods:

  • Identification of astrovirus coat protein as a C1 inhibitor.
  • Biochemical analysis of the interaction between astrovirus coat protein and C1q.
  • Assessment of the inhibitory effects on C1 complex activation and classical pathway function.

Main Results:

  • The astrovirus coat protein binds to the A-chain of C1q, effectively inhibiting C1 complex activation.
  • This inhibition suppresses both spontaneous and antibody-mediated classical pathway activation.
  • The study reports the first instance of a non-enveloped virus inhibiting complement and a viral inhibitor of C1.

Conclusions:

  • The astrovirus coat protein represents a novel class of C1 inhibitors.
  • This viral protein demonstrates significant potential as an anti-complement therapeutic agent.
  • Targeting C1 activation offers a promising strategy for managing complement-mediated inflammatory diseases.

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...